Juvaris BioTherapeutics News
Most Popular Juvaris BioTherapeutics Story
Emerging Drug Developer: Juvaris BioTherapeutics
Juvaris ramps up its clinical vaccine programs When Kleiner Perkins Caufield & Byers set up its pandemic and biodefense fund, its lead partner on the initiative--Thomas Monath, M.D.--was Read more...
Latest Headlines
- January 27, 2010
- June 29, 2009
- June 23, 2008
- June 23, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
